Application 076089
- Type
- ANDA
- Sponsor
- IVAX SUB TEVA PHARMS
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CIPROFLOXACIN | CIPROFLOXACIN | TABLET; ORAL | 100MG | No | No |
| 002 | CIPROFLOXACIN HYDROCHLORIDE | CIPROFLOXACIN HYDROCHLORIDE | TABLET;ORAL | EQ 250MG BASE | No | No |
| 003 | CIPROFLOXACIN HYDROCHLORIDE | CIPROFLOXACIN HYDROCHLORIDE | TABLET;ORAL | EQ 500MG BASE | No | No |
| 004 | CIPROFLOXACIN HYDROCHLORIDE | CIPROFLOXACIN HYDROCHLORIDE | TABLET;ORAL | EQ 750MG BASE | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0172-5312 | Ciprofloxacin | Ciprofloxacin | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 10544-606 | Ciprofloxacin hydrochloride | Ciprofloxacin hydrochloride | Blenheim Pharmacal, Inc. | ANDA | Current |
| 53808-0223 | Ciprofloxacin hydrochloride | Ciprofloxacin hydrochloride | State of Florida DOH Central Pharmacy | ANDA | Current |
| 66116-508 | Ciprofloxacin Hydrochloride | Ciprofloxacin Hydrochloride | MedVantx, Inc. | ANDA | Current |
| 67296-0543 | CIPROFLOXACIN HYDROCHLORIDE | ciprofloxacin hydrochloride tablet | RedPharm Drug Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 31073 | ORIG | 2004-06-15 |